<?xml version="1.1" encoding="utf-8"?>
<rdf:RDF xmlns:OMEXlib="http://omex-library.org/"
   xmlns:bqbiol="http://biomodels.net/biology-qualifiers/"
   xmlns:bqmodel="http://biomodels.net/model-qualifiers/"
   xmlns:dc="http://purl.org/dc/terms/"
   xmlns:foaf="http://xmlns.com/foaf/0.1/"
   xmlns:local="http://omex-library.org/NewOmex.omex/NewModel.rdf#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
  <rdf:Description rdf:about="http://omex-library.org/BIOMD0000000771.omex">
    <bqmodel:isDescribedBy rdf:resource="local:00001"/>
    <bqmodel:isDescribedBy rdf:resource="local:00002"/>
    <ns1:keyword xmlns:ns1="http://prismstandard.org/namespaces/basic/2.0/">Biomodels</ns1:keyword>
    <ns2:description xmlns:ns2="http://purl.org/dc/elements/1.1/">&lt;body xmlns="http://www.w3.org/1999/xhtml"&gt;
  &lt;pre&gt;This model describes the interactions between tumor cells and virus particles, with particular reference to virus-induced syncytium formation and ultimately death of tumor cells. Dynamics of infected cells, and production of new virus particules by infected cells, is also included.&lt;/pre&gt;
&lt;/body&gt;</ns2:description>
    <ns3:title xmlns:ns3="http://purl.org/dc/elements/1.1/">Modeling of cancer virotherapy with recombinant measles viruses</ns3:title>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <ns4:identifier xmlns:ns4="http://purl.org/dc/elements/1.1/"
       rdf:resource="http://identifiers.org/pubmed/11309314"/>
    <ns5:label xmlns:ns5="http://www.w3.org/2000/01/rdf-schema#">Wodarz D. Viruses as antitumor weapons: defining conditions for tumor remission. Cancer research 61, 8: 3501-7 (2001).</ns5:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00002">
    <ns6:identifier xmlns:ns6="http://purl.org/dc/elements/1.1/"
       rdf:resource="http://identifiers.org/doi/10.1016/j.jtbi.2008.01.016"/>
    <ns7:label xmlns:ns7="http://www.w3.org/2000/01/rdf-schema#">Željko Bajzer, Thomas Carr, Krešimir Josić, Stephen J. Russell &amp; David Dingli. Modeling of cancer virotherapy with recombinant measles viruses. Journal of Theoretical Biology 252, 1 (2008).</ns7:label>
  </rdf:Description>
</rdf:RDF>

